≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    Best Seller
    Tesamorelin research peptide - high purity lyophilized powder for laboratory research
    3ml Vial

    10MG

    $130
    In Stock
    Bulk Discounts

    Buy 3+ for $123.50 each and save 5%

    Buy 5+ for $117.00 each and save 10%

    Buy 10+ for $110.50 each and save 15%

    This product is for research purposes only. Not for human consumption.

    Purity: >98% (HPLC verified)

    Formulation: Lyophilized powder

    Molecular Formula: C221H366N72O67S

    Molecular Weight: 5135.77 g/mol

    CAS Number: 218949-48-5

    PubChem CID: 16137828

    Tesamorelin Molecular Structure

    Tesamorelin

    GHRH Analogs

    Overview

    This material is provided for controlled laboratory research and analytical characterization only.

    Mechanism of Action

    Tesamorelin acts as an agonist at the growth hormone-releasing hormone receptor (GHRHR), a G-protein coupled receptor on somatotroph cells in the anterior pituitary gland. Binding to GHRHR activates adenylyl cyclase, leading to an increase in intracellular cyclic AMP (cAMP).

    Growth Hormone Release

    Elevated cAMP levels activate protein kinase A (PKA), which in turn phosphorylates transcription factors such as CREB (cAMP response element-binding protein). This process upregulates the transcription of the growth hormone gene, resulting in the synthesis and pulsatile secretion of endogenous growth hormone.

    By stimulating the pituitary, this mechanism of action functions within the body's existing endocrine feedback systems, which include regulation by IGF-1 and somatostatin.

    Effects on Adipose Tissue

    Secreted growth hormone, both directly and through stimulation of insulin-like growth factor-1 (IGF-1), has been observed to have metabolic effects. In vitro and in vivo models show these effects include stimulation of lipolysis in adipocytes and promotion of fatty acid oxidation.

    Research Findings

    Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

    Research Applications

    • Studies on HIV-associated lipodystrophy
    • Growth hormone axis and GHRH receptor pharmacology
    • Cardiovascular risk factor research
    • Metabolic effects of antiretroviral regimens
    • Age-related visceral fat accumulation research
    • Lipid metabolism and dyslipidemia research
    • Insulin resistance and glucose metabolism studies
    • GHRH analog pharmacology and development

    Laboratory Handling & Limitations

    This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

    Laboratory Handling

    Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

    Research Limitations

    Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.

    Scientific References

    Research Use Only

    This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.